Emergent BioSolutions (EBS -0.6%) COO Daniel Abdun-Nabi lays out one of the company's biggest...

|About: Emergent BioSolutions Inc. (EBS)|By:, SA News Editor

Emergent BioSolutions (EBS -0.6%) COO Daniel Abdun-Nabi lays out one of the company's biggest driver for sales at the JPMorgan HealthCare Conference, saying the threat of a biological attack on the U.S. keeps the government's need to stockpile BioThrax very high. The latest contract with the Feds provides for delivery of the drug through Q3 of 2016. (transcript)